Leah C Byrne

Title: Innovations of Leah C Byrne

Introduction

Leah C Byrne is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of biotechnology, particularly in the development of innovative solutions for ocular diseases. With a total of two patents to her name, her work has garnered attention in the scientific community.

Latest Patents

Leah's latest patents include groundbreaking inventions. The first patent focuses on conjugates comprising Adeno-Associated Viruses (AAVs) and CAS9 polypeptides. This invention provides an AAV with an exterior surface that includes peptide tags, allowing it to bond with a binding-partner. The second patent addresses compositions and methods for treating ocular diseases. This patent presents recombinant AAV virions with altered capsid proteins, enhancing their ability to cross barriers between intravitreal fluid and retinal cells, thus improving infectivity compared to wild-type AAV.

Career Highlights

Leah has worked at prestigious institutions, including the University of California and the University of Pittsburgh. Her research has focused on advancing gene therapy techniques and improving treatment options for retinal diseases.

Collaborations

Leah has collaborated with notable colleagues, including Timothy P Day and David V Schaffer. These partnerships have contributed to her innovative research and development efforts.

Conclusion

Leah C Byrne's contributions to biotechnology and her innovative patents highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in the treatment of ocular diseases.